Abstract non disponibile

Bibliographic Details
Main Authors:	Johanna Wapling, Seema Srivastava, Miranda Shehu-Xhilaga, Gilda Tachedjian
Format:	Article
Language:	English
Published:	AboutScience Srl 2007-01-01
Series:	Drug Target Insights
Subjects:	HIV-1 antiretroviral drugs drug targets assembly maturation budding
Online Access:	https://journals.aboutscience.eu/index.php/dti/article/view/1318

Similar Items

Addressing Antiretroviral Drug Resistance with Host-Targeting Drugs—First Steps towards Developing a Host-Targeting HIV-1 Assembly Inhibitor
by: Jaisri R. Lingappa, et al.
Published: (2021-03-01)

Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages
by: Stefano Aquaro, et al.
Published: (2020-01-01)

Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding
by: Johanna Wapling, et al.
Published: (2007-01-01)

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
by: Reynolds Steven J, et al.
Published: (2012-12-01)

Determinants of adherence to antiretroviral drugs among people living with HIV/AIDS in the Ife-Ijesa zone of Osun state, Nigeria
by: Muhammed O. Afolabi, et al.
Published: (2009-04-01)

HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Paraná, Brazil
by: Paula Virginia Michelon Toledo, et al.

An RNA-binding compound that stabilizes the HIV-1 gRNA packaging signal structure and specifically blocks HIV-1 RNA encapsidation
by: Carin K. Ingemarsdotter, et al.
Published: (2018-03-01)

Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance
by: Soo-Yon Rhee, et al.
Published: (2021-05-01)

Antiretroviral drug resistance among U.S. veterans living with human immunodeficiency virus 1
by: Rahul Mahapatra, et al.
Published: (2019-03-01)

Genotypic resistance mutations to antiretroviral drugs in HIV-1 B and non-B subtypes from Cuba
by: Ruibal-Brunet Ignacio J., et al.
Published: (2001-01-01)

Reverse Transcriptase Inhibitors Nanosystems Designed for Drug Stability and Controlled Delivery
by: Fedora Grande, et al.
Published: (2019-04-01)

HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China
by: Xianwu Pang, et al.
Published: (2021-02-01)

Budding of a Retrovirus: Some Assemblies Required
by: Kevin M. Rose, et al.
Published: (2020-10-01)

Posaconazole: A Review of Drug Interactions with HIV Antiretroviral Agents
by: Mara Poulakos, et al.
Published: (2014-03-01)

Treatment outcome of HIV-1 infected children on antiretroviral therapy in the Limpopo Province of South Africa
by: Folefoc, Asongna Theresia
Published: (2015)

Wrapping up the bad news – HIV assembly and release
by: Meng Bo, et al.
Published: (2013-01-01)

HIV-1 subtypes and mutations associated to antiretroviral drug resistance in human isolates from Central Brazil Subtipos e mutações associadas à resistência aos anti-retrovirais em isolados de HIV-1 do Distrito Federal
by: Daniela Marreco Cerqueira, et al.
Published: (2004-09-01)

Genetic diversity of human immunodeficiency virus-1 isolates in Paraná, Brazil
by: Paula Virginia Michelon Toledo, et al.

Role of Ezrin Phosphorylation in HIV-1 Replication
by: Haruka Kamiyama, et al.
Published: (2018-08-01)

Promiscuous, Multi-Target Lupane-Type Triterpenoids Inhibits Wild Type and Drug Resistant HIV-1 Replication Through the Interference With Several Targets
by: Luis M. Bedoya, et al.
Published: (2018-04-01)

Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study
by: Dan Yuan, et al.
Published: (2020-06-01)

Maraviroc – a CCR5 antagonist for the treatment of HIV-1 infection
by: Elna eVan Der Ryst
Published: (2015-06-01)

HIV-1 Maturation: Lessons Learned from Inhibitors
by: Alex B. Kleinpeter, et al.
Published: (2020-08-01)

Synchronous and metachronous malignant melanomas arising in a human immunodeficiency virus-positive patient after the commencement of highly active antiretroviral therapy treatment: a case report
by: Sharad P. Paul, et al.
Published: (2021-07-01)

Level of Medication Adherence and Its Associated Factors among Patients Receiving Antiretroviral Therapy at a Tertiary Care Hospital in South India
by: Varadharaj Sakthivel, et al.
Published: (2020-06-01)

Potential interactions in a cohort of elderly hiv-positive patients
by: María Núñez-Núñez, et al.
Published: (2018-07-01)

PREVALENCE OF DRUG RESISTANT HIV STRAINS IN HIV-INFECTED PATIENTS OF REPRODUCTIVE AGE
by: N. Babii
Published: (2017-09-01)

Tetraspanins, Another Piece in the HIV-1 Replication Puzzle
by: Henar Suárez, et al.
Published: (2018-08-01)

The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection
by: Anna Halling Folkmar Andersen, et al.
Published: (2020-04-01)

Human rights discourses around the provision of antiretroviral drugs to HIV positive pregnant women in South Africa: implications for social work
by: Tesfamichael, Misgina Gebregiorgis
Published: (2008)

Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
by: Marta Iglis Oliveira, et al.
Published: (2018-10-01)

Evaluation of Oral Antiretroviral Drugs in Mice With Metabolic and Neurologic Complications
by: Fuu-Jen Tsai, et al.
Published: (2018-09-01)

The Challenge of Potential Drug–Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China
by: Huan Xia, et al.
Published: (2020-05-01)

HIV-1 drug resistance among untreated patients in India: Current status
by: Pachamuthu Balakrishnan, et al.
Published: (2006-01-01)

Effect of nevirapine, efavirenz and lopinavir/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria
by: Sikiru Olatunji Usman, et al.
Published: (2020-11-01)

A hyperkeratotic drug reaction in a patient on antiretroviral therapy
by: Kayla H. Felix, MS, et al.
Published: (2020-12-01)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
by: Martinez Valrie, et al.
Published: (2012-07-01)

Will Drug Resistance against Dolutegravir in Initial Therapy Ever Occur?
by: Mark eWainberg, et al.
Published: (2015-04-01)

Genetic diversity of human immunodeficiency viruses and antiretroviral therapy
by: M R Bobkova
Published: (2016-11-01)

Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique
by: Andrea De Luca, et al.
Published: (2017-09-01)